Raras
Buscar doenças, sintomas, genes...
Neoplasia escamosa da superfície ocular
ORPHA:659744CID-10 · D48.7DOENÇA RARA

O câncer do pulmão (português brasileiro) ou cancro do pulmão (português europeu), também conhecido como neoplasia pulmonar, é uma doença caracterizada pelo crescimento celular descontrolado em tecidos do pulmão. Se não for tratado, esse tumor pode se espalhar para fora do pulmão por um processo chamado de metástase, acometendo órgãos adjacentes e, eventualmente, se disseminando para outras partes do corpo. A maioria dos tumores que começam no pulmão são cânceres derivados das células epiteliais. Os principais tipos de câncer de pulmão são o adenocarcinoma(AC), o carcinoma de pulmão de células escamosas (CPCE), o carcinoma de pulmão de grandes células (CPGP) e o carcinoma de pulmão pequenas células (CPCP).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Neoplasia escamosa da superfície ocular é um tumor pré-maligno ou maligno que surge na conjuntiva ou córnea. Apresenta-se como lesão elevada, opaca ou pigmentada, com potencial de progressão para carcinoma escamoso invasivo.

Pesquisas ativas
2 ensaios
2 total registrados no ClinicalTrials.gov
Publicações científicas
602 artigos
Último publicado: 2026 Jan-Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.03
United States
Início
Adolescent
+ adult, childhood, elderly
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: D48.7
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico602PubMed
Últimos 10 anos200publicações
Pico202564 papers
Linha do tempo
2026Hoje · 2026🧪 2023Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Neoplasia escamosa da superfície ocular

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
454 papers (10 anos)
#1

Imiquimod Treatment for Conjunctival Melanoma In Situ or Ocular Surface Squamous Neoplasia.

JAMA ophthalmology2026 Jan 01

There are limited effective treatment options for diffuse conjunctival melanoma in situ (MIS), diffuse conjunctival intraepithelial neoplasia, and squamous cell carcinoma. There is a need for a more effective treatment with less ocular adverse effects than mitomycin C for MIS and 5-fluorouracil for ocular surface squamous neoplasia (OSSN). To evaluate the outcomes of compounded imiquimod 5% in ophthalmic petrolatum-based ointment for diffuse conjunctival MIS or OSSN. This was an interventional case series study at a tertiary referral center conducted from June 2024 to March 2025. Patients with a histological diagnosis of either conjunctival intraepithelial neoplasia (CIN), conjunctival squamous cell carcinoma, conjunctival MIS, or conjunctival melanoma with adjacent clinical primary acquired melanosis (PAM) were included in the study. Compounded imiquimod 5% ointment applied to the conjunctival surface 5 days per week for 12 weeks at a minimum (range, 12-15 weeks) along with a topical antibiotic. Histological resolution of MIS or OSSN. This case series included 5 patients (mean [SD] age, 77.4 [6] years; 4 female [80%]). At 12 weeks of treatment, there was complete clinical and histological response of CIN with moderate dysplasia, partial histological response (downgrade from squamous cell carcinoma to CIN with moderate dysplasia), and no histological recurrence of positive margins of squamous cell carcinoma excision. At 12 weeks of treatment, there was partial clinical response of diffuse MIS with mild persistence of epithelial pigmentation at the corneal limbus at the 7-o'clock position; however, there was complete histological response in the areas of initial map biopsy. At 15 weeks of treatment, there was complete clinical and histological response of PAM. Of the 5 patients, all experienced ophthalmic adverse events only affecting the ocular surface and eyelids. All ocular surface adverse events resolved within 1 to 2 weeks of drug holiday or completing treatment. Study results suggest that, although definitive safety and efficacy cannot be determined across only 5 cases, compounded imiquimod 5% ointment may be a safe and effective approach to manage diffuse conjunctival MIS or OSSN. Longer-term follow-up with larger number of cases is warranted.

#2

Artificial Intelligence for Diagnostic Guidance in Ocular Surface Disorders.

Journal of clinical medicine2026 Feb 25

Artificial intelligence (AI) has been explored as a promising diagnostic aid for ocular surface diseases (OSDs). The spectrum of OSD ranges from highly prevalent benign conditions such as dry eye disease (DED) to rare but potentially dangerous disorders, including ocular surface squamous neoplasia (OSSN) and conjunctival melanoma. This review provides an overview of current applications of AI across the major categories of ocular surface pathology and specifically highlights anterior segment imaging modalities, including slit-lamp examination, optical coherence tomography (OCT), and in vivo confocal microscopy (IVCM). Meibography, tear film dynamics, biochemical profiling, and other DED-related measures are also examined. Across these domains, reported AI model performance matches or exceeds that of ophthalmologists, offering consistent, reproducible, and accurate approaches for guiding diagnosis. However, studies with limited external or prospective validation, variable labeling strategies, and small, device-specific datasets predominate in the current literature, thereby limiting generalizability. Large multicenter datasets, standardized diagnostic frameworks, multimodal integration, and prospective trials that assess human-AI cooperation in practical settings should be an emphasis in future research. By filling these gaps, AI systems could advance from experimental tools to clinically reliable applications that improve access and diagnostic accuracy in the care of ocular surface disease and tumors.

#3

Immunohistochemistry analysis of P16INK4a in pre-invasive ocular surface squamous neoplasia tissue samples infected and not infected by human papilloma virus at an academic laboratory in Northern Tshwane.

Experimental eye research2026 Mar 05

Ocular surface squamous neoplasia (OSSN) encompasses a wide range of benign and malignant tumours that arise from the conjunctiva and cornea. Tumour progression involves various genetic and epigenetic changes affecting oncogenes. The tumour suppressor gene P16INK4a serves as a key biomarker for high-risk humanpailloma virus (HR-HPV) infection in squamous neoplasms. This study assessed the prognostic significance of P16INK4a in pre-invasive ocular surface squamous neoplasia tissue samples. This retrospective study analysed 58 formalin fixed paraffin embedded (FFPE) tissue samples of OSSN with known HPV results for the expression of P16INK4a immunohistochemistry marker at an academic laboratory in Tshwane. Data was analysed using STATA v16.1 software, and descriptive and inferential statistics were used to summarise the study findings. The study analysed OSSN samples of 35 females (60.34%) and 23 males (39.66%), with a mean age of 41.8 years. The overall prevalence of P16INK4a among the study samples was 22.4% (13/58). In HPV-positive samples, the prevalence of P16INK4a was 76.9% (10/13). The P16INK4a was detected in both high-risk (HR) and low-risk (LR) HPV positive conjunctival intraepithelial neoplasia (CIN) grade III cases. There was a statistically significant association between P16INK4a and HPV genotypes, with p-values of 0.033 and 0.045 for both linear array (LA) and real time polymerase chain reaction (RT-PCR) techniques, respectively. A lower prevalence of P16INK4a was observed in HPV-negative OSSN samples and a fair prevalence of P16INK4a was noted in HPV-positive OSSN samples with combined HPV detection techniques. The relationship between P16INK4a with prognosis and HPV infection in OSSN remains inconclusive.

#4

Deep learning-based diagnostic model for ocular surface neoplastic diseases.

American journal of ophthalmology2026 Feb 24

To develop a deep learning (DL) model for diagnosing ocular surface tumors and evaluating its diagnostic performance. Development of a deep learning diagnosis algorithm. A total of 1,491 ocular surface images representing seven diseases-nevus (28 eyes), limbal dermoid (144), MALT lymphoma (20), ocular surface squamous neoplasia (OSSN; 138), melanoma (14), pinguecula (29), and pterygium (1,118)-were captured using slit-lamp microscopy. A YOLOv5-based DL model was trained using five-fold cross-validation. Diagnostic performance was compared using 299 external validation images assessed by eight corneal specialists, seven board-certified ophthalmologists, and eight residents. The model achieved a positive predictive value (PPV) of 96.0%, outperforming the corneal specialists (95.0 ± 2.1%), board-certified ophthalmologists (82.6 ± 11.9%), and residents (81.9 ± 10.7%). Disease-specific PPVs were: nevus 75.0%, limbal dermoid 93.5%, MALT lymphoma 57.9%, OSSN 87.0%, melanoma 38.5%, pinguecula 82.1%, and pterygium 96.7%. The area under the curve (AUC) was: nevus 0.897 (95% confidence interval [CI], 0.810 - 0.983), limbal dermoid 0.998 (95%CI, 0.996 -1.000), MALT lymphoma 0.894 (95%CI, 0.794 - 0.993), OSSN 0.954 (95%CI, 0.933 - 0.975), melanoma 0.966 (95%CI, 0.919 - 1.000), pinguecula 0.954 (95%CI, 0.912 - 0.995), and pterygium 0.984 (95%CI, 0.976 - 0.992). Sensitivities were: nevus 0.643, limbal dermoid 0.993, MALT lymphoma 0.550, OSSN 0.681, melanoma 0.357, pinguecula 0.793, and pterygium 0.991. Specificities were: nevus 0.996, limbal dermoid 0.993, MALT lymphoma 0.995, OSSN 0.990, melanoma 0.995, pinguecula 0.997, and pterygium 0.898. The deep learning model demonstrated high diagnostic accuracy for common ocular surface tumors such as pterygium and limbal dermoid, while diagnostic performance for rare malignancies, including melanoma and MALT lymphoma, remains limited and requires further refinement. We developed a deep learning model that demonstrated promising performance in identifying ocular surface neoplastic diseases, suggesting its potential as a supportive diagnostic tool in ophthalmic practice.

#5

Imaging of Ocular Surface Lesions Using Anterior Segment Optical Coherence Tomography.

Clinical &amp; experimental ophthalmology2026 Feb 18

Ocular surface lesions encompass a wide spectrum of entities ranging from benign degenerative lesions to non-invasive and invasive malignant tumours. Accurate clinical differentiation is essential to ensure timely management. In this manuscript, we describe a series of benign and malignant ocular surface lesions and their clinical and specific imaging findings on anterior segment optical coherence tomography (AS-OCT), highlighting the diagnostic utility of this non-invasive imaging modality. We characterise ocular surface squamous neoplasia, pterygia, Salzmann's nodular degeneration, conjunctival melanoma, primary acquired melanosis, conjunctival nevus, conjunctival lymphoma, benign reactive lymphoid hyperplasia and conjunctival amyloidosis. This series underscores the growing role of AS-OCT in supporting clinical assessment, guiding biopsy decisions and monitoring response to therapy in patients with ocular surface lesions. Its integration into routine practice offers a valuable, non-invasive supplement to slit-lamp biomicroscopy and histopathology.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC419 artigos no totalmostrando 198

2026

Management and outcomes of ocular surface squamous neoplasia at a tertiary hospital, South Africa.

Eye (London, England)
2026

Artificial Intelligence for Diagnostic Guidance in Ocular Surface Disorders.

Journal of clinical medicine
2026

Immunohistochemistry analysis of P16INK4a in pre-invasive ocular surface squamous neoplasia tissue samples infected and not infected by human papilloma virus at an academic laboratory in Northern Tshwane.

Experimental eye research
2026

Deep learning-based diagnostic model for ocular surface neoplastic diseases.

American journal of ophthalmology
2026

Imaging of Ocular Surface Lesions Using Anterior Segment Optical Coherence Tomography.

Clinical &amp; experimental ophthalmology
2026

Prolonged stability of 1% 5-FU eye drops as topical chemotherapy for ocular surface squamous neoplasia.

The ocular surface
2026

Ocular Surface Squamous Neoplasia Masqueraders.

Seminars in ophthalmology
2026

Utilizing artificial intelligence for the diagnosis of ocular surface squamous neoplasia with ultrasound biomicroscopy images.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Viral eye: Emerging insights into corneal and ocular surface viral infections.

World journal of virology
2025

Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression.

Scientific reports
2025

Hippo Signaling Transduction Pathway Deregulation in Eye Diseases.

Maedica
2025

Establishment of a nomogram model to predict malignant risk in patients with ocular surface squamous neoplasia and ocular surface squamous epithelial tumors.

Frontiers in oncology
2026

Ocular surface squamous neoplasia: insights from 67 cases at a Quebec tertiary center.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

Corneal Actinic Keratosis in an Elderly Farmer: A Rare Case Report.

Case reports in ophthalmology
2025

Ocular Surface Squamous Neoplasia Masquerading as Viral Keratitis.

Ophthalmology
2026

Imiquimod Treatment for Conjunctival Melanoma In Situ or Ocular Surface Squamous Neoplasia.

JAMA ophthalmology
2026

Optical coherence tomography angiography in evaluating the response of ocular surface squamous neoplasia to topical immunotherapy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Incidence of Primary Acquired Melanosis Within Pterygium Specimens: A 13-Year Retrospective Study in a Canadian Tertiary Center.

Cornea
2025

Serum vascular endothelial growth factor in patients with nonmelanoma primary ocular malignancies: A possible potential biomarker of tumor progression and poor prognosis.

Oman journal of ophthalmology
2025

Incidental ocular surface squamous neoplasia in pterygia: a systematic review and meta-analysis.

The British journal of ophthalmology
2025

Topical 5-fluorouracil 1% versus surgical removal as a primary treatment modality for ocular surface squamous neoplasia: a comparison of recurrences and side effects.

BMC ophthalmology
2025

Space radiation and risk for ocular surface malignancies: Exposure risk, current mitigation strategies, and management considerations for a mission to Mars.

Life sciences in space research
2025

Infectious etiologies of conjunctival tumors.

Expert review of ophthalmology
2025

Topical Chemotherapy for Ocular Surface Squamous Neoplasia: A Review of Adverse Effects and Their Clinical Management.

Oncology research
2025

Early detection of ocular surface squamous neoplasia with corkscrew vascular pattern.

Clinical &amp; experimental optometry
2025

Correlation of histopathological features and clinical findings in pterygium.

Bioinformation
2025

Factors influencing delayed presentation of periorbital carcinoma requiring orbital exenteration.

Journal of the colleges of medicine of South Africa
2025

High-resolution optical coherence tomography for screening ocular surface tumors: Historical markers and future directions.

World journal of clinical cases
2026

Orbital Exenteration Trends at a Single Institution From 2011 to 2024.

Ophthalmic plastic and reconstructive surgery
2025

Solitary extramedullary plasmacytoma mimicking ocular surface squamous neoplasia in an elderly male: A case report.

World journal of clinical cases
2025

Deep Learning-Based Detection of Ocular Surface Squamous Neoplasia from Ocular Surface Images.

Ocular oncology and pathology
2026

Ocular Surface Squamous Neoplasia: A Cohort Study and Updates in the Pathogenesis, Diagnosis, and Medical Management.

Seminars in ophthalmology
2025

Human papillomavirus-associated conjunctival squamous intraepithelial neoplasia.

Clinical &amp; experimental optometry
2025

Premalignant and Malignant Ocular Surface Squamous Cell Neoplasia: A Retrospective Hospital-Based Study Spanning 18 Years.

Journal of the West African College of Surgeons
2025

Stevens-Johnson Syndrome as a Risk Factor for Ocular Surface Squamous Neoplasia in a Pediatric Patient.

Cureus
2025

Pediatric Ocular Surface Squamous Neoplasia in the Absence of Known Risk Factors and Systemic Conditions: A Case Series.

Ocular oncology and pathology
2025

Primary Corneal Squamous Cell Carcinoma Confined to the Cornea: An Unusual Presentation of Ocular Surface Squamous Neoplasia Without Limbal Involvement.

Cureus
2025

Spontaneously resolved invasive conjunctival squamous cell carcinoma with anterior chamber invasion in low-grade lymphoma patient.

American journal of ophthalmology case reports
2025

EZH2 expression in corneal and conjunctival intraepithelial neoplasia and squamous cell carcinoma: a potential marker for diagnosis.

International ophthalmology
2025

Treatment of corneoscleral mixed hemangioma by intrastromal lenticule transplantation in a case of xeroderma pigmentosum: a case report.

BMC ophthalmology
2025

Ocular surface squamous neoplasia: Growth, diagnosis, and treatment.

European journal of ophthalmology
2025

US Incidence and Demographics of Ocular Surface Squamous Neoplasia in the IRIS® Registry 2014-2021.

Ophthalmology
2025

IFNα2b/5-FU inhibits proliferation and cell cycle of squamous carcinoma cell line Cal27.

International journal of ophthalmology
2025

Ocular surface squamous neoplasia masquerades: Clinical profile and outcome.

Indian journal of ophthalmology
2025

Evaluation of Impression Cytology for Diagnosis of Ocular Surface Squamous Neoplasia in Two Kenyan Tertiary Hospitals.

Cancer investigation
2025

Presumed reactivation of herpes simplex virus-associated endothelial keratitis after treatment with topical interferon-α 2b for ocular surface squamous neoplasia.

BMC ophthalmology
2025

Classification of ocular surface diseases: Deep learning for distinguishing ocular surface squamous neoplasia from pterygium.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Anterior Segment Swept-Source Optical Coherence Tomography in Ocular Surface Tumors and Simulating Lesions and Correlation With Histopathologic Diagnosis.

Cornea
2025

Basal cell carcinoma and squamous cell carcinoma of the conjunctiva in a single lesion.

American journal of ophthalmology case reports
2025

Artificial intelligence to enhance the diagnosis of ocular surface squamous neoplasia.

Scientific reports
2025

Update in the Diagnosis and Management of Ocular Surface Squamous Neoplasia (OSSN).

Journal of clinical medicine
2025

A systematic review and meta-analysis of the association of human papilloma virus infections with ocular surface squamous neoplasia.

Cancer epidemiology
2025

Interferon alpha-2b versus 5-fluorouracil as primary treatment modalities for ocular surface squamous neoplasia: a study of 116 eyes.

International ophthalmology
2025

Clinico-tomographic-pathological correlation in nodulo-ulcerative ocular surface squamous neoplasia: a study of 16 cases.

International ophthalmology
2025

Detection of Ocular Surface Squamous Neoplasia Using Artificial Intelligence With Anterior Segment Optical Coherence Tomography.

American journal of ophthalmology
2025

The critical role of primary care clinicians in the early detection of ocular surface squamous neoplasia.

South African family practice : official journal of the South African Academy of Family Practice/Primary Care
2025

Immune Checkpoint Inhibitors in the Treatment of Ocular Surface Cancers: A Review.

Seminars in ophthalmology
2025

Global incidence and trends of ocular cancer: A bibliometric analysis.

Advances in ophthalmology practice and research
2025

Oncological principles in the management of ocular surface squamous neoplasia - A Review.

Indian journal of ophthalmology
2025

Clinical profile and outcomes of ocular surface squamous neoplasia at the Philippine General Hospital: a retrospective study.

International journal of ophthalmology
2025

Successful management of large conjunctival squamous cell carcinoma with excisional biopsy, topical interferon, and amniotic membrane grafting: A case report.

International journal of surgery case reports
2025

Outcomes Following Primary Excision of Ocular Surface Squamous Neoplasia at a Tertiary Eye Care Centre in the Midwestern Region of Nepal.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
2024

Chemoimmunotherapy-Resistant Ocular Surface Squamous Neoplasia Managed With I-125 Brachytherapy.

Cornea
2024

Primary treatment of advanced ocular surface and adnexal squamous cell carcinoma with intravenous cemiplimab.

Orbit (Amsterdam, Netherlands)
2025

Electrochemotherapy with bleomycin for bilateral ocular squamous cell carcinoma in a horse.

Veterinary ophthalmology
2025

Topical 5-fluorouracil 1% as first-line therapy for giant ocular surface squamous neoplasia.

Journal francais d'ophtalmologie
2025

Nodulo-Ulcerative Ocular Surface Squamous Neoplasia in 27 Patients: Clinical Presentation, Management and Outcomes.

Seminars in ophthalmology
2024

Case report: Squamous cell carcinoma in situ of the cornea without involvement of the limbus and conjunctiva.

Frontiers in medicine
2025

Ocular surface squamous neoplasia: Update on genetics, epigenetics and opportunities for targeted therapy.

The ocular surface
2025

New combined treatments, surgery and high-dose-rate interventional radiotherapy (brachytherapy), in advanced ocular surface and eyelid cancers.

Translational oncology
2024

Anterior Segment Optical Coherence Tomography Angiography: A Review of Applications for the Cornea and Ocular Surface.

Medicina (Kaunas, Lithuania)
2024

Evaluation of the Cornea by Anterior Segment Optical Coherence Tomography in Diseases of the Cornea.

Cureus
2025

OSSN in South India: Clinical presentation, treatment outcomes, and histopathologic correlations.

Indian journal of ophthalmology
2025

Epidemiological profile and clinical characteristics of ocular and periocular tumors in North and Central India.

Indian journal of ophthalmology
2024

Metastatic conjunctival squamous cell carcinoma presenting as infectious sclerokeratouveitis.

American journal of ophthalmology case reports
2025

Single-Cell RNA Profiling of Ocular Adnexal Sebaceous Carcinoma Reveals a Complex Tumor Microenvironment and Identifies New Biomarkers.

American journal of ophthalmology
2024

Excision combined with ocular surface reconstruction followed by topical chemotherapy for ocular surface squamous neoplasia.

Japanese journal of ophthalmology
2024

Cytomorphological Spectrum of Ocular Surface Squamous Neoplasia in Elderly Age Group and Its Clinicopathological Correlation.

Journal of pharmacy &amp; bioallied sciences
2024

Ocular Surface Squamous Neoplasia In Situ Secondary to Bruton Tyrosine Kinase Inhibitor Therapy.

Eye &amp; contact lens
2025

Limbal Stem Cell Deficiency After Treatment of Ocular Surface Squamous Neoplasia.

Cornea
2024

Ocular Surface Squamous Neoplasia in Renal Transplant Patients.

Beyoglu eye journal
2024

Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes.

BMC ophthalmology
2024

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia.

Journal of visualized experiments : JoVE
2024

Corneal ocular surface squamous neoplasia: Case series and review of literature.

Oman journal of ophthalmology
2025

Primary conjunctival basal cell carcinoma treated with plaque brachytherapy: a rare case report.

Orbit (Amsterdam, Netherlands)
2024

Anterior lamellar corneoscleral keratoplasty for the management of corneal thinning following treatment with mitomycin-C and interferon to treat highly suspected ocular surface squamous neoplasia: a case report.

Arquivos brasileiros de oftalmologia
2025

Can high-resolution optical coherence tomography provide an optical biopsy for ocular surface lesions?

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2024

Health disparities in ocular oncology.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2024

An unusual presentation of conjunctival squamous cell carcinoma mistaken for a stye.

JAAD case reports
2024

Primary and tertiary management of ocular surface lesions in HIV-infected patients in Ehlanzeni, Mpumalanga Province.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2024

Primary Conjunctival Basal Cell Carcinoma Mimicking an Ocular Surface Squamous Neoplasia in a Young Adult Filipino: A Case Report and Literature Review.

Case reports in ophthalmological medicine
2024

Case report: Clinical features and management outcomes of isolated corneal intraepithelial neoplasia.

Frontiers in ophthalmology
2024

Novel automated non-invasive detection of ocular surface squamous neoplasia using artificial intelligence.

World journal of methodology
2024

Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.

International ophthalmology
2024

Clinicopathological Correlates of Ocular Surface Squamous Neoplasia.

Ocular oncology and pathology
2024

Update in ocular surface squamous neoplasia.

Revista da Associacao Medica Brasileira (1992)
2024

Nodulo-ulcerative squamous cell carcinoma of the conjunctiva mimicking necrotizing sclerokeratitis in a young patient.

American journal of ophthalmology case reports
2024

Conjunctival Intraepithelial Neoplasia Mimicking a Pigmentary Lesion in an HIV-Seropositive Indian Male.

Cureus
2024

Unusual presentation of ocular surface squamous neoplasia in a young healthy patient: A case report.

European journal of ophthalmology
2025

Topical 5-Fluorouracil 0.5% as primary treatment for Ocular Surface Squamous Neoplasia.

European journal of ophthalmology
2024

The prevalence of human papillomavirus in ocular surface squamous neoplasia in HIV positive and negative patients in a South African population.

Infection
2024

A UV-related risk analysis in ophthalmic malignancies: Increased UV exposure may cause ocular malignancies.

Advances in ophthalmology practice and research
2025

Ocular Surface Squamous Neoplasia with Coexistent Pterygia: A Study of 14 Cases and Review of Literature.

Seminars in ophthalmology
2024

Impact of Equine Ocular Surface Squamous Neoplasia on Interactions between Ocular Transcriptome and Microbiome.

Veterinary sciences
2024

Impression cytology of ocular surface in xeroderma pigmentosum.

Arquivos brasileiros de oftalmologia
2024

[Severe Conjunctival and Corneal Epithelial Dysplasia: A Case Series].

Klinische Monatsblatter fur Augenheilkunde
2024

Melanocytic ocular surface squamous neoplasia successfully managed with no-touch excisional biopsy, cryotherapy and amniotic membrane transplantation.

Eye (London, England)
2024

Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2024

Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon α-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital.

International ophthalmology
2024

Personalized treatment concepts in extraocular cancer.

Advances in ophthalmology practice and research
2024

Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025

Outcomes of Simple Limbal Epithelial Transplantation Without Amniotic Membrane Grafting in Unilateral Limbal Stem Cell Deficiency: A Case Series of 6 Patients.

Cornea
2024

Therapeutic Response to Treatment of a Papillomatous Ocular Surface Squamous Neoplasia With Intramuscular Human Papillomavirus Vaccine.

Cornea
2024

Punctal and Canalicular Stenosis Following Topical 1% 5-Fluorouracil Eye Drop Therapy for Ocular Surface Squamous Neoplasia.

Cornea
2023

Corneal Endothelial Toxicity Secondary to Topical 5-fluorouracil.

Middle East African journal of ophthalmology
2024

Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia.

The ocular surface
2024

Xeroderma Pigmentosum With Ocular Surface Squamous Neoplasia: A Case Report.

Cureus
2024

Ocular surface squamous neoplasia masquerading as pseudoepitheliomatous hyperplasia in chronic vernal keratoconjunctivitis.

GMS ophthalmology cases
2024

Variable presentations of six conjunctival/limbal ocular surface squamous neoplasia (OSSN) cases: How good is our clinical judgment evidenced by the correlation to the histopathological findings and diagnosis?

International journal of surgery case reports
2024

Ocular Surface Squamous Neoplasia: Changes in the Standard of Care 2003 to 2022.

Cornea
2024

Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management.

Eye (London, England)
2023

Molecular and epigenetic mechanisms governing ocular surface squamous neoplasia: opportunities for diagnostics.

Expert review of molecular diagnostics
2024

Remission of Ocular Surface Squamous Neoplasia.

Ophthalmology
2023

Predictive Value of the International Classification of Diseases, 9th Revision Codes for Identifying Ocular Oncology Diagnoses.

Ocular oncology and pathology
2024

Comparison of non-invasive diagnostic modalities for ocular surface squamous neoplasia at a tertiary hospital, South Africa.

Eye (London, England)
2024

Unveiling ocular surface squamous neoplasia within a conjunctival epithelial inclusion cyst.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2024

It Is All About the Angle: A Clinical and Optical Coherence Tomography Comparison of Corneal Ocular Surface Squamous Neoplasia and Corneal Pannus.

Cornea
2023

High-risk human papillomavirus-associated corneal/conjunctival intraepithelial neoplasia in a young patient.

American journal of ophthalmology case reports
2024

Periocular and ocular surface nonmelanoma skin cancer.

Clinics in dermatology
2024

Toluidine blue 1% eye drop versus optical coherence tomography for margin delimitation of ocular surface squamous neoplasia.

European journal of ophthalmology
2023

Anterior segment optical coherence tomography features of ocular surface squamous epithelial hyperplasia: A report of four cases.

Oman journal of ophthalmology
2024

Neoadjuvant Chemotherapy in a Case of Nonresectable Papillary Squamous Cell Carcinoma of the Palpebral Conjunctiva.

Ophthalmic plastic and reconstructive surgery
2023

Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.

BMC ophthalmology
2023

Promotor methylation in ocular surface squamous neoplasia development: epigenetics implications in molecular diagnosis.

Expert review of molecular diagnostics
2023

Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target.

Frontiers in oncology
2023

Asymptomatic chronic red eye: A surgical technique case report.

International journal of surgery case reports
2023

Invasive Acantholytic Ocular Surface Squamous Neoplasia: A Rare Case.

Cureus
2023

Demographics, clinical presentation and risk factors of ocular surface squamous neoplasia at a tertiary hospital, South Africa.

Eye (London, England)
2023

Prevalence of co-existent neoplasia in clinically diagnosed pterygia in a UK population.

Eye (London, England)
2023

Intraocular Spread of Ocular Surface Squamous Neoplasia Presenting as a Postoperative Anterior Chamber Opacity after Excisional Biopsy.

Case reports in ophthalmology
2023

Corneal squamous neoplasia: masquerades and management outcomes at a rural eyecare centre.

BMJ case reports
2023

Local ocular safety of the subconjunctival injection of cetuximab in rabbits.

BMC ophthalmology
2023

How Can We Diagnose Ocular Surface Squamous Neoplasia With Optical Coherence Tomography?

Cureus
2023

Amelanotic Melanoma Masquerading as Ocular Surface Squamous Neoplasia.

Ophthalmology
2023

Pigmented Inflamed Seborrheic Keratosis of the Bulbar Conjunctiva.

Ophthalmic plastic and reconstructive surgery
2023

Squamous Cell Carcinoma of the Conjunctiva in a Patient With Previous Squamous Cell Carcinoma of the Lower Lip.

Cureus
2023

Medical treatment for ocular surface squamous neoplasia.

Eye (London, England)
2023

Acute Fibrinous Anterior Uveitis in a Patient Treated With Topical Interferon-α2b for Ocular Surface Squamous Neoplasia With Uveitis Susceptibility.

Cornea
2023

Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany.

Klinische Monatsblatter fur Augenheilkunde
2022

The Management of Ocular Surface Squamous Neoplasia (OSSN).

International journal of molecular sciences
2024

Incidence of ocular surface squamous neoplasia in pterygium specimens.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2023

Corneal Molluscum Contagiosum Masquerading as Ocular Surface Squamous Neoplasia.

Ophthalmology
2023

Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.

The ocular surface
2023

Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak.

American journal of ophthalmology case reports
2022

Primary Basal Cell Carcinoma of the Conjunctiva.

Cureus
2022

Ocular surface squamous neoplasia in a patient following oral steroids for contralateral necrotising scleritis.

BMJ case reports
2023

Anterior segment optical coherence tomography in ocular surface tumours and simulating lesions.

Eye (London, England)
2023

Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study.

The ocular surface
2023

Brachytherapy as a curative option for ocular surface squamous neoplasia.

International ophthalmology
2023

Anterior segment optical coherence tomography characteristics of conjunctival papilloma as compared to papilliform ocular surface squamous neoplasia.

Eye (London, England)
2023

Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia.

Cancer immunology, immunotherapy : CII
2023

Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2022

Pegylated Interferon Alpha 2a for the Treatment of Ocular Surface Squamous Neoplasia.

Cornea
2023

Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor.

Journal of cancer research and clinical oncology
2022

Therapy Failure and Resistance Mechanism in Eyelid and Ocular Surface Tumors.

Neuro-Signals
2022

Ocular Surface Squamous Neoplasia: A 12-Month Prospective Evaluation of Incidence in Waikato, New Zealand.

Vision (Basel, Switzerland)
2022

Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.

Scientific reports
2023

Ocular surface squamous neoplasia with 360° limbal involvement: a study of 130 patients.

International ophthalmology
2023

Midterm results of conjunctival reconstruction with buccal mucosa and amniotic membrane after resecting ocular surface squamous neoplasia of the fornix.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2022

Iodine-125 plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion.

Oman journal of ophthalmology
2022

Bulbar conjunctival rhinosporidiosis mimicking ocular surface squamous neoplasia.

Indian journal of pathology &amp; microbiology
2022

Conjunctival myxoma masquerading as conjunctival lymphoma: A case report.

International journal of surgery case reports
2023

Clinicopathological profile, management and clinical outcomes in recurrent cases of ocular surface squamous neoplasia at a tertiary care centre.

International ophthalmology
2022

Clinicopathological characteristics of ocular surface squamous neoplasia: a 10-year review form a referral tertiary centre in Nigeria.

International ophthalmology
2022

OVOL1 immunohistochemical expression is a useful tool to diagnose invasion in ocular surface squamous neoplasms.

Archivos de la Sociedad Espanola de Oftalmologia
2022

Molluscum Contagiosum Masquerading as Ocular Surface Squamous Neoplasia.

Ophthalmology
2022

Topical Chemotherapy for Treating Ocular Surface Squamous Neoplasia with a Combination of Interferon α-2b and 5-Fluorouracil.

Ophthalmology and therapy
2023

Management of coexisting bilateral ocular surface disease in xeroderma pigmentosum - sequence and outcomes.

European journal of ophthalmology
2022

Metastatic conjunctival squamous cell carcinoma: a study of 5 patients.

International ophthalmology
2022

Epstein-Barr Virus, But Not Human Papillomavirus, Is Associated With Preinvasive and Invasive Ocular Surface Squamous Neoplasias in Zambian Patients.

Frontiers in oncology
2023

Clinical and Optical Coherence Tomography Comparison Between Ocular Surface Squamous Neoplasia and Squamous Metaplasia.

Cornea
2022

Association of high-risk human papillomavirus with ocular surface squamous neoplasia: a case-control study in Mexico.

Salud publica de Mexico
2023

Masquerade syndrome in ocular surface squamous neoplasia.

Arquivos brasileiros de oftalmologia
2022

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia.

Oman journal of ophthalmology
2022

Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.

The ocular surface
2022

Pterygium and Ocular Surface Squamous Neoplasia: Optical Biopsy Using a Novel Autofluorescence Multispectral Imaging Technique.

Cancers
2022

Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.

Journal of interferon &amp; cytokine research : the official journal of the International Society for Interferon and Cytokine Research
2022

Ocular surface squamous neoplasia in Northern Thailand: a 16-year review.

BMC ophthalmology
2022

The use of high resolution optical coherence tomography (HR-OCT) in the diagnosis of ocular surface masqueraders.

The ocular surface
2022

Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma.

Indian journal of ophthalmology
2022

Spontaneous rupture of ocular surface squamous neoplasia-a case report.

International journal of ophthalmology
2022

Occurrence of Occult Neoplasia in Pterygium Specimens Among Hispanic and Non-Hispanic Patients.

Current eye research
2022

Treatment challenges associated with a superiorly located bulbar conjunctival mass-case report and review of the literature.

American journal of ophthalmology case reports
2022

A case of sight threatening complications from topical 1% 5-fluorouracil in the treatment of ocular surface squamous neoplasia.

American journal of ophthalmology case reports
2023

Ocular surface squamous neoplasia with orbital tumour extension: risk factors and outcomes.

Eye (London, England)
2022

Ocular surface squamous neoplasia in India: a study of 438 patients.

International ophthalmology
2022

Histopathological spectrum of ocular surface squamous neoplasia: A retrospective study of 776 lesions.

Indian journal of pathology &amp; microbiology
2022

Visualizing Ocular Surface Squamous Neoplasia.

Ophthalmology
Ver todos os 419 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Neoplasia escamosa da superfície ocular.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Neoplasia escamosa da superfície ocular

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Imiquimod Treatment for Conjunctival Melanoma In Situ or Ocular Surface Squamous Neoplasia.
    JAMA ophthalmology· 2026· PMID 41296343mais citado
  2. Artificial Intelligence for Diagnostic Guidance in Ocular Surface Disorders.
    Journal of clinical medicine· 2026· PMID 41827158mais citado
  3. Immunohistochemistry analysis of P16INK4a in pre-invasive ocular surface squamous neoplasia tissue samples infected and not infected by human papilloma virus at an academic laboratory in Northern Tshwane.
    Experimental eye research· 2026· PMID 41791292mais citado
  4. Deep learning-based diagnostic model for ocular surface neoplastic diseases.
    American journal of ophthalmology· 2026· PMID 41748055mais citado
  5. Imaging of Ocular Surface Lesions Using Anterior Segment Optical Coherence Tomography.
    Clinical &amp; experimental ophthalmology· 2026· PMID 41705454mais citado
  6. Ocular surface squamous neoplasia in Malaysia: A 5-year review.
    Taiwan J Ophthalmol· 2026· PMID 41993658recente
  7. Pigmented versus nonpigmented ocular surface squamous neoplasia: A comparative study of 424 tumors.
    Taiwan J Ophthalmol· 2026· PMID 41993657recente
  8. Artificial Intelligence in Ocular Surface Tumors: Current Advances, Challenges, and Future Directions.
    Diagnostics (Basel)· 2026· PMID 41975814recente
  9. Lung metastasis with primary conjunctival mucoepidermoid carcinoma.
    Rom J Ophthalmol· 2025· PMID 41971202recente
  10. Case Report: Atypical ocular surface squamous cell carcinoma.
    Front Med (Lausanne)· 2026· PMID 41948573recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:659744(Orphanet)
  2. MONDO:0971056(MONDO)
  3. Busca completa no PubMed(PubMed)
  4. Artigo Wikipedia(Wikipedia)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Neoplasia escamosa da superfície ocular
Compêndio · Raras BR

Neoplasia escamosa da superfície ocular

ORPHA:659744 · MONDO:0971056
Prevalência
<1 / 1 000 000
CID-10
D48.7 · Neoplasia de comportamento incerto ou desconhecido de outras localizações especificadas
Ensaios
2 ativos
Início
Adolescent, Adult, Childhood, Elderly
Prevalência
0.03 (United States)
MedGen
UMLS
C4761284
EuropePMC
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades